Samyang Holdings Corporation
Financials
Valuation Metrics
Samyang Holdings Corporation's Market Cap is ₩4510B. At end of 2025 it was ₩4472B. Ranked #472 of 2,436 in KR market (top 19%), #302 of 787 on KOSPI (top 38%), #16 of 84 in Food, Beverage & Tobacco (top 19%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 451.04B KRW | KR#472/2,436 Sec#16/84 |
| Revenue | 3.32T KRW | KR#181/2,436 Sec#17/84 |
| Net Income | -301.83B KRW | KR—/2,436 Sec—/84 |
| Total Assets | 5.35T KRW | KR#166/2,436 Sec#6/84 |
| Net Assets | 2.76T KRW | KR#140/2,436 Sec#8/84 |
| Employees | 578 | KR#428/2,436 Sec#24/84 |
| Value | ||
| P/B | 0.16x | KR#67/2,436 Sec#2/84 |
| P/S | 0.14x | KR#217/2,436 Sec#19/84 |
| EV/EBITDA | 14.33x | KR#848/2,436 Sec#50/84 |
| FCF Yield | 28.98% | KR#210/2,436 Sec#22/84 |
| Profitability | ||
| ROE | -10.92% | KR#1,915/2,436 Sec#72/84 |
| ROA | -5.64% | KR#1,923/2,436 Sec#71/84 |
| Op. Margin | 3.21% | KR#1,178/2,436 Sec#53/84 |
| Revenue Growth | -3.19% | KR#1,624/2,436 Sec#63/84 |
| Earnings Growth | -9.58% | KR#984/2,436 Sec#40/84 |
| Financial Health | ||
| Debt Ratio | 93.56% | KR#305/2,436 Sec#9/84 |
| Total Debt | 1.32T KRW | KR#161/2,436 Sec#9/84 |
| FCF | 130.73B KRW | KR#149/2,436 Sec#10/84 |
| Cash | 246.01B KRW | KR#242/2,436 Sec#18/84 |
| Current Ratio | 1.02x | KR#1,793/2,436 Sec#47/84 |
| Net Debt/EBITDA | 10.10x | KR#1,273/2,436 Sec#56/84 |
| Dividend | ||
| Div. Yield | 6.06% | KR#181/2,436 Sec#10/84 |
| Div. Growth | 0.00% | KR—/2,436 Sec—/84 |
| Performance | ||
| 1Y Return | 6.44% | KR#544/2,436 Sec#11/84 |
| 1M Return | 1.04% | KR#591/2,436 Sec#30/84 |
| From 52W High | -23.05% | KR#210/2,436 Sec#18/84 |
| 1Y MDD | -30.34% | KR#218/2,436 Sec#19/84 |
| Trading | ||
| Volume | 7,906 shares | KR#2,044/2,436 Sec#58/84 |
| Foreign Own. | 8.48% | KR—/2,436 Sec—/84 |
| Per Share | ||
| EPS | -24,384 KRW | KR—/2,436 Sec—/84 |
| BPS | 271,474 KRW | KR#37/2,436 Sec#5/84 |
Company Info
Samyang Holdings, established in 1924 and listed in 1968, is a holding company with six subsidiaries, including Samyangsa. Its subsidiaries operate in food, chemical, and other businesses. The food ingredients sector is expanding by building dedicated allulose and prebiotic factories, while the chemical division enhances competitiveness through the development of high-value-added ion exchange resins. The pharmaceutical division fosters continuous growth via its anticancer drug business and overseas export contracts. Samyang Holdings was established in 1924 and is headquartered in Jongno-gu, Seoul.